|
楼主 |
发表于 2008-12-10 09:02:23
|
显示全部楼层
71-7-第七节 预 后
CSS最常见的死因是继发于冠状动脉血管炎的心肌炎和心肌梗死。经治疗的CSS的1年存活率为90%,5年存活率为62 ,未接受治疗的5年生存率为 25 。早期而有效的治疗预后较好,死亡率较 PAN低,5年存活率为78.9%,主要死亡原因是心肌受累导致难治性的心力衰竭。影响CSS预后的危险因素有:①氮质血症(肌Of > 1. 5 mg /dl) ;②蛋白尿(>1g/d) ;③胃肠道受累;④心肌病;⑤中枢神经系统受累。危险因素越多,则预后越差。
& X6 u$ [. J2 |# B& a9 Q1 w ( 曾小峰 艾脉心 )7 Q; O; `- x4 l: M# g( H7 w* C
参考文献:' \5 g2 M# j4 y1 K! v
& G& F/ c1 r$ U1 b1 v5 a: r8 Z
Calabrese LH, Hoffman GS, Guillevin L. Therapy of resistant systemicvasculitis. Polyarteritis, Churg-Strauss syndrome, Wegener'sculitis group disorders.一57granulomatosis, and hypersensitivity vas Rheum Dis Clin North Am, 1995. 21: 41-57( W8 B( ?/ N) a H& d
* r- H8 V. L+ P3 v% C8 C Guillevin L, Cohen P, Gayraud M. Churg-Strauss syndrome.Clinical studyand long-term follow-up of 96 patients. Medicine,1999.78:26一37 3 D: z& T0 v) @* {
. O# x9 M& t& k3 Q" S
Guillevin L, Le THD, Godeau P, et al. Clinical findings andprognosis of polyarteritis nodosa and Churg-Strauss angiitis: Astudy in 165 patients. Br J Rheumatol 1988.27:258一264
/ i; J2 r! u: b/ H" C L+ [8 n( N$ t. v% m: k$ V8 E
Guillevin L, Lhote F, Gallais V, et al. Gastrointestinal tractinvolvement in polyarteritis nodosa and Churg-Strauss syndrome.Ann Med Interne,1995.146:260一267
0 T* D8 k! Y7 r; s) L6 N- G* b* u8 v, |
Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors inpolyarteritis nodosa and Churg-Strauss syndrome: A prospectivestudy of 342 patients. Medicine, 1996. 75:17一28
6 r/ ^& M) r6 Q) q2 K" Y6 j" r8 Q& @) [) u4 ^
Lhote F, Guillevin L. Polyarteritis nodosa, microscopicpolyangiitis and Churg-Strauss syndrome: Clinical aspects andtreatment. Rheum Clin North Am 1995. 21: 911一947
- u, Z! [0 r f: B. L6 L4 Z# x0 _. f
Lhote F, Cohen P, Guillevin L Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss yndrome. Lupus, 1998. 7:238一258
% j# |+ d: C0 c
' @- D, D$ L6 a( q( z) |) o5 A/ o- wSehgal M, Swanson JW, DeRemee RA,et al. Neurologic manifestations of Churg-Strauss syndrome.Mayo Clin Proc,1995.70:337一341 |
|